Summary: Hydroxysteroid sulfotransferase catalyzing bile acid sulfation plays an essential role in protection against lithocholic acid (LCA)-induced liver toxicity. Hepatic levels of Sult2a is up to 8-fold higher in farnesoid X receptor-null mice than in the wild-type mice. Thus, the in‰uence of FXR ligand (chenodeoxycholic acid (CDCA) and LCA) feeding on hepatic Sult2a expression was examined in FXRnull and wild-type mice. Hepatic Sult2a protein content was elevated in FXR-null and wild-type mice fed a LCA (1z and 0.5z) diet. Treatment with 0.5z CDCA diet decreased hepatic Sult2a to 20z of the control in wild-type mice, but increased the content in FXR-null mice. Liver Sult2a1 (St2a4) mRNA levels were reduced to 26z in wild-type mice after feeding of a CDCA diet, while no decrease was observed on Sult2a1 mRNA levels in FXR-null mice after CDCA feeding. A signiˆcant inverse relationship (r 2 ＝0.523) was found between hepatic Sult2a protein content and small heterodimer partner (SHP) mRNA level. PCN-mediated increase in Sult2a protein levels were attenuated by CDCA feeding in wild-type mice, but not in FXR-null mice. Human SULT2A1 protein and mRNA levels were decreased in HepG2 cells treated with the FXR agonists, CDCA or GW4064 in dose-dependent manners, although SHP mRNA levels were increased. These results suggest that SULT2A is negatively regulated through CDCA-mediated FXR activation in mice and humans.
Introduction
Sulfotransferases (SULT) are phase II metabolizing enzymes that catalyzes sulfation of various endogenous and exogenous chemicals. 1, 2) Hydroxysteroid sulfotransferase (SULT2A) is a cytosolic enzyme expressed abundantly in enterohepatic tissues such as liver and intestine, and also in steroidogenic tissue such as the adrenal cortex.
3) SULT2A catalyzes the sulfation of drugs, environmental chemicals and endogenous steroids such as dehydroepiandrosterone (DHEA), estrogen and bile acids. 4, 5) SULT2A-mediated sulfation increases the hydrophilicites of bile acids and facilitates their clearance from the body. Because bile acid sulfation is a main metabolic pathway for bile acid excretion, SULT2A is a critical enzyme for bile acid homeostasis. About 95z of bile acids excreted in bile are reabsorbed in the intestine and thus changes in the level of hepatic SULT2A can disrupt bile acid homeostasis in enterohepatic tissues. SULT2A is also considered to play a major role in the protection against toxic bile acidinduced liver injury in enterohepatic tissues. SULT2A preferably catalyzes the sulfation of hydrophobic and toxic bile acids such as LCA. A protective role of Sult2a against LCA-induced hepatotoxicity was demonstrated by using farnesoid X receptor (FXR)-null female mice constitutively expressing higher levels of Sult2a protein.
6) The increase in the production of hepatic Sult2a-mediated 3a-sulfated TLCA and the e‹cient fecal excretion contributes to the protection against LCAinduced toxicity (submitted for publication). Two Sult2a mRNAs (Sult2a1 (St2a4) and Sult2a2 (St2a9)) that share high homology, were isolated from mice 7, 8) and one mRNA (SULT2A1) has been isolated from humans. 5, 9, 10) . Mouse Sult2a enzymes are expressed to higher extents in the female. Because of the e‹cient bile acid sulfating activity in female mice as well as humans, female mice represent a feasible model for bile acid sulfation in humans.
FXR, a member of the nuclear receptor superfamily, is expressed abundantly in liver, intestine and adrenal.
11)
The involvement of FXR in bile acid and lipid homeostasis was demonstrated by using FXR-null mice. 12) FXR is activated by several bile acids such as CDCA. [13] [14] [15] FXR regulates a variety of genes involved in the metabolism and transport of the lipids such as bile acid and cholesterol. FXR stimulates the expression of Bsep, small heterodimer partner (SHP) and Mrp2, whereas FXR directly represses the expression of apolipoprotein A-I and apolipoprotein C-III, and indirectly suppresses the expression of CYP7A1 and Ntcp through the induction of SHP. [16] [17] [18] CDCA activation of FXR has been shown to stimulate rat SULT2A1 transcription via the FXR response element (IR0) in HepG2 cells. 19) . Furthermore, it was demonstrated that pregnane X receptor (PXR), constitutive androstane receptor (CAR) and vitamin D receptor (VDR) also bind the rat and mouse IR0 elements and enhance the reporter gene activity. [20] [21] [22] [23] The Sult2a expression level, however, was increased in FXR-null and PXR-null female mice as compared with that of wild-type mice. 6) In the present study, SULT2A expression levels were determined using FXR-null mice and HepG2 cells to clarify the involvement of FXR signaling in the suppression of SULT2A gene expression. These results suggest that SULT2A is negatively regulated by activation of FXR with CDCA.
Materials and Methods
Materials: CDCA, LCA, tauroLCA (TLCA), glycoLCA (GLCA), cholic acid (CA), deoxycholic acid (DCA), ursodeoxycholic acid (UDCA), pregnenolone 16a-carbonitrile (PCN) and dehydroepiandrosterone (DHEA) were purchased from Sigma-Aldrich Co. (St. Louis, MO). GW4064 was kindly provided by Dr. Timothy M. Willson (GlaxoSmithKline, Research Triangle Park, NC).
Animal treatment and sample collection: FXR-null female mice 12) were housed under standard 12-h light W 12-h dark cycle. Prior to the administration of special diets, the mice were fed standard rodent chow (CE-2, Clea Japan) and water ad libitum for acclimation. Agematched groups of 8-to 12-week-old animals were used for all experiments. The mice were fed the control diet (CE-2) mixed with 0.5z and 1.0z (w W w) LCA for 9 days or 0.5z CDCA for 5 days. The mice were fed the control diet or the diet mixed with 0.5z (w W w) CDCA for 5 days and injected with PCN (100 mg W kg, ip) for the last 3 days.
Hepatic bile acid concentration: Hepatic 3a-hydroxy bile acid concentrations were estimated by an enzyme-colorimetric method using the Total bile acidtest kit from Wako (Wako Pure Chemicals, Osaka, Japan). Hepatic LCA and CDCA contents were measured by HPLC as previously described. 24) Cell culture: HepG2 cells were plated in 10 cm culture dishes (Falcon Scientiˆc Co., Oxnard, CA) at 3×10 6 cells and cultured in Dulbecco's modiˆed Eagle's medium (DMEM) containing 10z fetal calf serum. The cells were cultured for 24-h and then treated with CDCA, GW4064 or vehicle (DMSO) for 48-h. The cells were cultured in serum-free DMEM during chemical treatment.
Immunoblot analysis: Cytosolic proteins (30 mg W lane) were loaded onto a 9z polyacrylamide gel, isolated and transferred to nitrocelluloseˆlters. Theˆlter was immunostained with a polyclonal antibody prepared against the puriˆed recombinant rat SULT2A1 protein (1:1000 dilution) that reacts with mouse Sult2a 25) and a polyclonal antibody against the puriˆed recombinant human SULT2A1 protein 26) (1:1000 dilution) for human SULT2A1. The stainedˆlters were scanned with an Epson GT-8700 scanner, and the band intensities measured by use of the NIH image (version 1.59) software (Bethesda, MD).
Expression and puriˆcation of Sult2a proteins: Mouse Sult2a cDNAs were obtained from wild-type mouse liver by reverse transcription-polymerase chain reaction (RT-PCR). Sult2a cDNA fragments, containing a sequence of the recognition site of enterokinese next to the N-terminal methionine of the native form, were obtained by RT-PCR and ligated into the prokaryotic expression vector, pQE30 (QIAGEN). The plasmid DNA was transformed into Escherichia coli, M15 (pREP4). Recombinant Sult2a proteins were expressed and puriˆed from bacterial cytosols by nickelnitrilotriacetic acid a‹nity chromatography. The fused portion of recombinant Sult2a proteins was removed to yield native proteins for standard of immunoblot analyses by enterokinase.
Analysis of mRNA levels: Total RNAs were prepared from livers and HepG2 cells using the RNAgents Total RNA Isolation System (Promega, Madison, WI), and RNA concentrations were determined by measuring the absorbance at 260 nm using a spectrophotometer (Beckman DU 640). Messenger RNA levels of diŠerentially expressed genes were analyzed A. Immunoblot analyses of hepatic Sult2a proteins. Hepatic cytosol was prepared from FXR-null and wild-type mice fed a LCA diet for 9 days or fed a CDCA diet for 5 days. Hepatic cytosols (30 mg) were analyzed by immunoblotting with antibody to rat SULT2A1. Intensiˆed staining was shown on the top. B. Quantiˆcation of hepatic Sult2a protein levels of mice fed a LCA diet, or a CDCA diet. Data are shown as the mean±S.D. (n＝4). * , signiˆcant diŠerence from control group (pº0.05). ** , (pº0.01). UT, untreated. m; mouse, h; human. 317 FXR Signaling Represses SULT2A Expression using RT-PCR as previously described. 24) Single strand cDNAs were constructed using an oligo(dT) primer with the Ready-to-Go You-Prime First-strand Beads kit (Amersham Pharmacia Biotech AB, Uppsala, Sweden). These cDNAs provided templates for PCRs using speciˆc primers at a denaturation temperature of 949 C for 30 sec, an annealing temperature of 579 C-619 C (619 C for Sult2a1) for 30 sec, and an elongation temperature of 729 C for 30 sec in the presence of dNTPs and Taq polymerase. The PCR cycle numbers were titrated for each primer pair to assure ampliˆca-tion in linear range. The reaction was completed at 7 min incubation at 729 C and PCR products were analyzed in a 2z agarose gel (w W v) containing ethidium bromide for visualization. Their intensities were measured by use of the NIH image (version 1.59) software (Bethesda, MD). The speciˆc forward and reversal primers for the genes examined by PCR were Fig. 2 . Hepatic LCA and CDCA concentrations in bile acid-fed mice.
Liver homogenates were prepared from FXR-null and wild-type mice fed a LCA diet for 9 days or fed a CDCA diet for 5 days. Hepatic LCA and CDCA concentrations were determined by HPLC. Combined amounts of tauro and free forms are shown. Data are shown as the mean±S.D. (n＝4). ND, not detected. UT, untreated. shown in Table 1 .
Statistical analysis: All values are expressed as the means±SD. All data were analyzed by unpaired Student's t test or Dunnett's multiple comparisons test for signiˆcant diŠerences between the mean values of each group.
Results
In‰uence of bile acid feeding on hepatic content of Sult2a protein: Hepatic Sult2a expression levels were increased in FXR-null and PXR-null female mice as compared to their wild-type counterparts.
6) Hepatic contents of Sult2a protein in bile acid-treated mice were determined by immunoblotting using rat SULT2A1 antibody to assess the in‰uence of the bile acid-related nuclear receptors in hepatic Sult2a expression. Consistent with our previous data, Sult2a protein contents were markedly higher in livers of FXR-null female mice than in wild-type mice (Fig. 1A, B) . Hepatic Sult2a protein contents were increased 2.4-fold in wild-type mice fed a 1z LCA diet. The Sult2a contents were also increased 1.8-fold in wild-type mice fed a 0.5z LCA diet. Signiˆcant increases (2.4-fold) in Sult2a protein contents were also observed in FXR-null nice fed a 1z LCA diet. Hepatic Sult2a protein contents were markedly decreased to 20z of control in wild-type mice fed a 0.5z CDCA diet (Fig. 1B) . In contrast to wild-type mice, Sult2a was signiˆcantly increased 2.1-fold in FXR-null mice after feeding CDCA.
Hepatic LCA and CDCA concentrations: To understand the mechanism of the change in hepatic Sult2a expression in bile acid-fed mice, hepatic LCA and CDCA concentrations were measured in mice fed a LCA or CDCA diet. FXR-null female mice constitutively expressing high levels of Sult2a protein did not accumulate LCA in livers. 6) As expected, hepatic LCA concentrations were 6.9-fold higher in wild-type mice than in FXR-null mice after feeding a 1z LCA diet for 9 days (Fig. 2) . In addition, CDCA was detected as the major bile acid in livers of FXR-null and wild-type mice fed LCA (0.5z and 1z) diets. In the FXR-null mice fed a 1z LCA diet, hepatic CDCA concentrations were higher than LCA. Furthermore, hepatic LCA concentrations were 3.4-fold higher in wild-type mice fed a 0.5 z LCA diet than in FXR-null mice fed a 1z LCA diet. In CDCA fed mice, CDCA was detected as the main bile acid component in liver together with trace amounts of LCA. Hepatic CDCA concentrations were 1.8-fold higher in FXR-null mice fed a 0.5z CDCA diet than those in wild-type mice. Hepatic levels of LCA and CDCA in FXR-null and wild-type mice fed a control diet were below the detection limits under our conditions.
Expression and characterization of mouse Sult2a1 and Sult2a2: Two distinct mRNAs of mouse Sult2a were isolated from C57BL W 6 wild-type mice by RT-PCR. One matched with Sult2a1 (Accession Number:L02335), and the other showed two nucleotide diŠerences from the reported Sult2a2 cDNA (Accession Number:L27121) isolated from BALB W c mice. This cDNA was judged to correspond to Sult2a2 in the C57BL W 6 strain. Although a clear correlation between individual cytosolic LCA sulfation activity and Sult2a protein content was demonstrated, 6) the correspondence between Sult2a mRNA and protein remained unclear. Thus, recombinant Sult2a (Sult2a1 and Sult2a2) proteins were expressed in Escherichia coli. The recombinant Sult2a1 protein showed the same electrophoretic mobility on SDS-PAGE as the major cytosolic Sult2a protein detected by antibody generated against rat SULT2A1, whereas the recombinant Sult2a2 protein exhibited a mobility diŠerent from the cytosolic Sult2a protein (data not shown). These results indicate that Sult2a protein quantiˆed by Western blotting corresponds to Sult2a1.
Hepatic Sult2a1 mRNA levels in CDCA fed mice: A. Changes in mRNA levels of hepatic mouse Sult2a1 and mouse SHP were analyzed by RT-PCR. Hepatic mRNAs were prepared from FXRnull and wild-type mice fed a 0.5z CDCA diet for 5 days. Speciˆc primers described in Table 1 Data on FXR-null and wild-type mice fed a 0.5z CDCA diet or a control diet are indicated. Wild-type mice and FXR-null mice were fed a control diet or the diet containing 0.5z CDCA for 5 days and injected with PCN (100 mg W kg, ip) the last 3 days. Hepatic cytosols were analyzed by immunoblotting with antibody to rat SULT2A1. The expression level of Sult2a protein was normalized to that of control wild-type mice. Data are shown as the mean±S.D. (n＝4). **, signiˆcant diŠerence from corresponding PCN-treated groups (pº0.01).
Hepatic contents of Sult2a protein were higher in female FXR-null mice than in the corresponding wild-type mice. These results suggest the possibility that FXR mediated suppression of Sult2a expression. Clear decreases in hepatic Sult2a content in CDCA-fed mice further support thisˆnding. Liver Sult2a1 mRNA level was detected by RT-PCR. Under the conditions employed, Sult2a2 mRNA was undetectable. Hepatic levels of Sult2a1 mRNA were reduced to 26z of the wild-type control in mice fed a CDCA diet, which was consistent with the change in Sult2a protein levels. However, no signiˆcant decrease in Sult2a1 mRNA levels were observed in the FXR-null mice fed a CDCA diet (Fig. 3A, B) . As expected, the prototypical FXR target gene, SHP mRNA levels were increased 1.9-fold in wild-type mice fed a CDCA diet. The same treatment decreased SHP mRNA levels in FXR-null mice, suggest- Total mRNAs and cytosols were prepared from HepG2 cells treated with CDCA, GW4064 or vehicle (DMSO) for 48 hrs. A. Human SULT2A1 and SHP mRNA levels. Human SULT2A1 and SHP mRNA levels were analysed by RT-PCR using speciˆc primers described in Table 1 . B. Relative SULT2A mRNA levels. The levels were analysed by conventional PCR method. Data are shown as the mean±S.D. (n＝4). *, signiˆcant diŠerence from control group (pº0.05). **, (pº0.01). C. Human SULT2A1 protein contents. Human SULT2A1 protein was detected by immunoblots with antibody to human recombinant SULT2A1.
ing a CDCA-mediated suppression of SHP expression. A signiˆcant inverse relationship (r 2 ＝0.523) was found between Sult2a protein levels and SHP mRNA levels (Fig. 4) . Furthermore, r 2 value is increased to 0.672 if two points that show more than 1.5 of SHP mRNA level are omitted.
In‰uence of CDCA feeding on Sult2a expression in PCN-treated wild-type mice: Rodent SULT2A in liver is increased after treatment with PXR ligands such as dexamethasone and PCN. 27) Thus, the in‰uence of CDCA feeding on Sult2a induction by PCN was examined. Sult2a protein contents were increased 9.0-fold in PCN-treated wild-type mice, compared to those in control mice. (Fig. 5) . The contents were reduced in PCN-treated wild-type mice fed a 0.5z CDCA diet to 35z level of PCN-treated wild-type mice fed a control diet. On the other hand, no signiˆcant diŠerences in Sult2a contents were observed between both the groups in FXR-null mice.
Human SULT2A1 expression in HepG2 cells: The in‰uence of FXR agonists on human SULT2A1 levels in HepG2 cells was assessed to determine whether human SULT2A1 was also negatively regulated by FXR signaling. Human SULT2A1 mRNA levels were signiˆcantly decreased in HepG2 cells after addition of CDCA in a dose-dependent manner (Fig. 6A, B) . In contrast, SHP mRNA levels were increased in these cells. These results are consistent with the in vivo data in the mice fed a 0.5z CDCA diet. Human SULT2A1 mRNA levels were also decreased in HepG2 cells treated with GW4064, a selective nonsteroidal FXR agonist. Human SULT2A1 protein levels were also decreased in HepG2 cells after addition of 100 mM of CDCA (Fig. 6C) .
Discussion
The present study demonstrates that SULT2A is negatively regulated by CDCA signaling in vivo. The negative in‰uence of CDCA feeding on Sult2a expression is likely to be FXR-dependent as suggested by the inverse relationship (r 2 ＝0.523) between levels of SHP mRNA and Sult2a protein. Human SULT2A1 mRNA levels were also reduced in HepG2 cells after treatment with CDCA or GW4064, similar to the results obtained with mouse Sult2a1 expression in vivo. Consistent with these results, human SULT2A1 mRNA levels are decreased in cultured human primary hepatocytes treated with CDCA. 28) Although some diŠerences in transcriptional regulation has been demonstrated in rodent and human SULT2A genes, human SULT2A1 expression is also likely to be suppressed by CDCA activation of FXR. However, it cannot be excluded that a CDCA-mediated FXR-independent mechanism such as the c-Jun N-terminal kinase (JNK) signaling 29, 30) plays a role in suppression of SULT2A expression.
It should also be noted that Sult2a protein contents were increased in mice fed a LCA diet, thus supporting the view that Sult2a is involved in protection against LCA-induced toxicity through sulfation of LCA. LCA serves as an agonist for PXR and VDR [31] [32] [33] and it was shown that transcription of rodent SULT2A is positively regulated by several nuclear receptors such as PXR, CAR, VDR and PPARa. [20] [21] [22] [23] 28, 34, 35) Thus, hepatic Sult2a protein is likely at least in part induced by PXR and CAR signaling through LCA.
Although 3-to 4-fold higher hepatic LCA concentrations were observed in wild-type mice fed a 0.5z LCA diet, as compared to LCA in FXR-null mice fed a 1z LCA diet, the extents of increase in Sult2a protein was lower in the former mice than that in the latter. These results also support the idea that CDCA-mediated FXR activation negatively regulates hepatic Sult2a expression because CDCA as well as LCA were detected as the main bile acid component in these mice. LCA serves as a weak agonist for FXR, while it strongly antagonizes CDCA-mediated FXR activation. 36) Thus, Sult2a1 expression in LCA-fed mice might be regulated by complex networks with negative FXR signaling and positive PXR W CAR signaling through CDCA and LCA, respectively. Furthermore, PCN-mediated increases in Sult2a protein levels were attenuated by CDCA feeding in wild-type mice. This result also suggests the possibility of CDCA-mediated negative FXR signaling and the potential for cross-talk between FXR and PXR in the regulation of Sult2a expression.
It was reported that CDCA-mediated FXR activation stimulates reporter CAT expression directed via the rat SULT2A1 promoter from -366 to ＋38 in HepG2 cells. 19) An FXR binding site, designated IR0, in this promoter region was also demonstrated in this study. Furthermore, PXR, CAR and VDR were found to bind to this element and enhance reporter activity. The IR0 element has also been detected in the mouse Sult2a1 promoter, but not in the human SULT2A1 promoter. Our results using FXR-null mice and HepG2 cells suggest that the mouse and human SULT2As are negatively regulated by FXR signaling. Two possible mechanisms for negative transcriptional regulation of target genes by FXR activation have been proposed. One is an indirect mechanism via FXR-mediated induction of negative transcription factor such as SHP. The other is a direct mechanism via FXR binding to the negative response element of the target gene. Further studies are needed to understand whether FXR regulates SULT2A expression directly or indirectly.
SULT2A seems to facilitate the excretion of toxic bile acids such as LCA from body because human and mouse SULT2A predominantly catalyze LCA sulfation, but not primary bile acid, CA and CDCA sulfation. 6) Under physiological conditions, the main components of mouse hepatic bile acids, muricholic acid and cholic acid, are eŠectively conjugated with amino acids but not sulfated and excreted into bile and about 95z of the biliary amino-conjugated bile acids are reabsorbed in the intestine. On the other hand, under cholestasis, toxic bile acids such as LCA accumulate in liver and liver injury is accelelated. Thus, the nuclear receptor-mediated enhancement of bile acid sulfation that stimulates the excretion of toxic bile acids into feces might be an adaptive response to protect from bile acid-induced toxicity. Indeed, feeding of the primary bile acid CDCA suppresses hepatic Sult2a expression in wild-type mice, whereas LCA feeding increases its expression. Rodent CYP7A1, the rate-limiting enzyme in bile acid synthesis, is positively and negatively regulated by LXR signaling and FXR W SHP signaling respectively. These play key roles in bile acid and cholesterol homeostasis. SULT2A, involved in the bile acid excretion, seems to also be positively and negatively regulated by several bile acids through a complex nuclear receptor network to maintain bile acid homeostasis.
The hepatic bile acid components and concentration were analyzed and correlated with the hepatic Sult2a expression proˆle. Hepatic bile acid concentrations were signiˆcantly diŠerent between wild-type mice and FXRnull mice after feeding bile acids. Furthermore, unlike in vitro LCA treatment, CDCA was detected as the main bile acid component in livers of LCA-fed mice, suggesting hepatic accumulation of the LCA metabolite, CDCA in vivo. Hepatic bile acids are critical determinants for hepatic gene expression regulated by nuclear receptors such as PXR, CAR and FXR. The analyses of hepatic bile acids are thus important in order to compare wild-type mice and null mice treated with bile acids.
In the present study, we have demonstrated that SULT2A-mediated LCA sulfation is negatively regulated by CDCA-mediated FXR activation. Further studies are needed to elucidate the precise mechanism for this suppression and to determine the physiological signiˆcance of this response.
